Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
69
datasets available to search
ShareScore release 0.9.0
Dataset results
69 results for “certolizumab”
Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis
ClinicalTrials.gov study NCT01443364. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis
ClinicalTrials.gov study NCT01087788. IPD Sharing: Not stated. Countries: 15. Publications: 8.
Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients
ClinicalTrials.gov study NCT01288287. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT00717236. IPD Sharing: Not stated. Countries: 7. Publications: 4.
A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis
ClinicalTrials.gov study NCT03051217. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid
ClinicalTrials.gov study NCT00160641. IPD Sharing: Not stated. Countries: 13. Publications: 3.
A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis
ClinicalTrials.gov study NCT00152386. IPD Sharing: Not stated. Countries: 13. Publications: 13.
Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA)
ClinicalTrials.gov study NCT01098201. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Assess How Well Certolizumab Pegol Works in Patients With Moderate to Severe Plaque Psoriasis as Part of Routine Clinical Practice
ClinicalTrials.gov study NCT04053881. IPD Sharing: NO. Countries: 9. Publications: 1.
A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active R
ClinicalTrials.gov study NCT00160602. IPD Sharing: Not stated. Countries: 15. Publications: 8.
Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis
ClinicalTrials.gov study NCT02430909. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Prediction of Response to Certolizumab Pegol Treatment by Functional MRI of the Brain
ClinicalTrials.gov study NCT01864265. IPD Sharing: Not stated. Countries: 3. Publications: 1.
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
ClinicalTrials.gov study NCT03152058. IPD Sharing: NO. Countries: 2. Publications: 22.
Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's Disease
ClinicalTrials.gov study NCT00333788. IPD Sharing: Not stated. Countries: 12. Publications: 0.
A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT04740814. IPD Sharing: NO. Countries: 1. Publications: 0.
Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)
ClinicalTrials.gov study NCT01374971. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease
ClinicalTrials.gov study NCT00552344. IPD Sharing: Not stated. Countries: 18. Publications: 0.
A Study of Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid Arthritis
ClinicalTrials.gov study NCT02151851. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
ClinicalTrials.gov study NCT01190410. IPD Sharing: Not stated. Countries: 3. Publications: 0.
An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044
ClinicalTrials.gov study NCT02319642. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.